AI-Driven segmentation and morphogeometric profiling of epicardial adipose tissue in type 2 diabetes

人工智能驱动的2型糖尿病心外膜脂肪组织分割和形态几何分析

阅读:2

Abstract

BACKGROUND: Epicardial adipose tissue (EAT) is associated with cardiometabolic risk in type 2 diabetes (T2D), but its spatial distribution and structural alterations remain understudied. We aim to develop a shape-aware, AI-based method for automated segmentation and morphogeometric analysis of EAT in T2D. METHODS: A total of 90 participants (45 with T2D and 45 age-, sex-matched controls) underwent cardiac 3D Dixon MRI, enrolled between 2014 and 2018 as part of the sub-study of the Swedish SCAPIS cohort. We developed EAT-Seg, a multi-modal deep learning model incorporating signed distance maps (SDMs) for shape-aware segmentation. Segmentation performance was evaluated using the Dice similarity coefficient (DSC), the 95% Hausdorff distance (HD95), and the average symmetric surface distance (ASSD). Statistical shape analysis combined with partial least squares discriminant analysis (PLS-DA) was applied to point cloud representations of EAT to capture latent spatial variations between groups. Morphogeometric features, including volume, 3D local thickness map, elongation and fragmentation index, were extracted and correlated with PLS-DA latent variables using Pearson correlation. Features with high-correlation were identified as key differentiators and evaluated using a Random Forest classifier. RESULTS: EAT-Seg achieved a DSC of 0.881, a HD95 of 3.213 mm, and an ASSD of 0.602 mm. Statistical shape analysis revealed spatial distribution differences in EAT between T2D and control groups. Morphogeometric feature analysis identified volume and thickness gradient-related features as key discriminators (r > 0.8, P < 0.05). Random Forest classification achieved an AUC of 0.703. CONCLUSIONS: This AI-based framework enables accurate segmentation for structurally complex EAT and reveals key morphogeometric differences associated with T2D, supporting its potential as a biomarker for cardiometabolic risk assessment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。